{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T14:14:13Z","timestamp":1774275253258,"version":"3.50.1"},"reference-count":103,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Prostate cancer represents a highly prevalent malignancy affecting men globally, necessitating precise staging and risk stratification for effective patient management. Multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen positron emission tomography (PSMA PET) have individually revolutionized the diagnosis and management of prostate cancer. Recent developments emphasize the integration of these imaging modalities to improve detection capabilities, inform therapeutic interventions, and facilitate personalized management. This narrative article reviews existing literature on the clinical utilization of mpMRI and PSMA PET in prostate cancer. Key areas encompass initial diagnosis, both local and systemic staging, detection of biochemical recurrence, and their influence in treatment strategies. The integration of mpMRI and PSMA PET offers complementary insights, with mpMRI demonstrating superior capability in local tumor characterization and PSMA PET enhancing the detection of nodal and distant metastases. Quantitative imaging biomarkers, including apparent diffusion coefficient (ADC) and standardized uptake values (SUV), have the potential to improve risk stratification and inform personalized treatment strategies. Hybrid imaging techniques may improve diagnostic accuracy and guide decisions regarding surgery, radiotherapy, and systemic treatment. The integration of mpMRI and PSMA PET allows a potentially transformative advancement in the realm of precision imaging for prostate cancer. This integrated approach can improve diagnostic accuracy, better define disease extent, and support personalized management strategies.<\/jats:p>","DOI":"10.3390\/medicina62030610","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:07:06Z","timestamp":1774271226000},"page":"610","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating Multiparametric MRI and PSMA PET Imaging in Prostate Cancer: Toward a Unified Diagnostic and Risk-Stratification Paradigm"],"prefix":"10.3390","volume":"62","author":[{"given":"Rosa Alba","family":"Pugliesi","sequence":"first","affiliation":[{"name":"Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Via del Vespro 129, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3808-0785","authenticated-orcid":false,"given":"Roberto","family":"Cannella","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Via del Vespro 129, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Ben Mansour","sequence":"additional","affiliation":[{"name":"Department of Radiology, H\u00f4pital de Morges, Chemin du Cr\u00eat 2, 1110 Morges, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4125-2206","authenticated-orcid":false,"given":"Daniele","family":"Di Biagio","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Centre, San Pietro Fatebenefratelli Hospital\u2014Express Diagnostics, Via Cassia 600, 00189 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8397-1640","authenticated-orcid":false,"given":"Pierpaolo","family":"Alongi","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Via del Vespro 129, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mallah, H., Diabasana, Z., Soultani, S., Idoux-Gillet, Y., and Massfelder, T. (2025). Prostate Cancer: A Journey Through Its History and Recent Developments. Cancers, 17.","DOI":"10.3390\/cancers17020194"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: A review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"key":"ref_3","unstructured":"McDowell, S. (2024, September 27). Cancer in Men: Prostate Cancer Is #1 for 118 Countries Globally. Available online: https:\/\/www.cancer.org\/research\/acs-research-news\/prostate-cancer-is-number-1-for-118-countries-worldwide.html."},{"key":"ref_4","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kania, E., Janica, M., Nesterowicz, M., Modzelewski, W., Cybulski, M., and Janica, J. (2025). Advances and Challenges in Prostate Cancer Diagnosis: A Comprehensive Review. Cancers, 17.","DOI":"10.3390\/cancers17132137"},{"key":"ref_7","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"42649","DOI":"10.1007\/s11042-025-20786-2","article-title":"Multimodality imaging in prostate cancer diagnosis using artificial intelligence: Basic concepts and current state-of-the-art","volume":"84","author":"Ayyad","year":"2025","journal-title":"Multimed. Tools Appl."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Combes, A.D., Palma, C.A., Calopedos, R., Wen, L., Woo, H., Fulham, M., and Leslie, S. (2022). PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer. Diagnostics, 12.","DOI":"10.3390\/diagnostics12112594"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.eururo.2016.06.011","article-title":"Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force","volume":"71","author":"Moore","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Alongi, P., Morea, S., Cannella, R., Pugliesi, R.A., Messina, C., and Di Biagio, D. (2026). The Rise of Total-Body PET\/CT: Advancing Molecular Imaging Toward Early Cancer Detection and Potential Future Application in Prevention Healthcare. J. Clin. Med., 15.","DOI":"10.3390\/jcm15010311"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): A prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","article-title":"Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis","volume":"77","author":"Perera","year":"2020","journal-title":"Eur. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/tomography8030124","article-title":"Dynamic Contrast Enhanced Study in Multiparametric Examination of the Prostate\u2014Can We Make Better Use of It?","volume":"8","author":"Krajina","year":"2022","journal-title":"Tomography"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2533583","DOI":"10.2214\/AJR.25.33583","article-title":"PI-RADS Version 2.1 for prostate MRI interpretation: Associations of study quality and cancer detection metrics\u2014A systematic review and meta-analysis","volume":"226","author":"Nedelcu","year":"2025","journal-title":"Am. J. Roentgenol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wo\u017anicki, P., Westhoff, N., Huber, T., Riffel, P., Froelich, M.F., Gresser, E., von Hardenberg, J., M\u00fchlberg, A., Michel, M.S., and Schoenberg, S.O. (2020). Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters. Cancers, 12.","DOI":"10.3390\/cancers12071767"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","article-title":"Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis","volume":"77","author":"Drost","year":"2020","journal-title":"Eur. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","article-title":"Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-na\u00efve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study","volume":"75","author":"Cornel","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/bco2.184","article-title":"Performance of multiparametric prostate magnetic resonance imaging validated by targeted and systematic transperineal biopsies","volume":"4","author":"Hsi","year":"2022","journal-title":"BJUI Compass"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Messina, C., Bignone, R., Bruno, A., Bruno, A., Bruno, F., Calandri, M., Caruso, D., Coppolino, P., Robertis, R., and Gentili, F. (2020). Diffusion-Weighted Imaging in Oncology: An Update. Cancers, 12.","DOI":"10.3390\/cancers12061493"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1148\/radiol.16151133","article-title":"Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers","volume":"280","author":"Park","year":"2016","journal-title":"Radiology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.euo.2022.03.004","article-title":"[68Ga]Ga-PSMA Versus [18F]PSMA Positron Emission Tomography\/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature","volume":"5","author":"Evangelista","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/thno.37894","article-title":"18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging","volume":"10","author":"Werner","year":"2020","journal-title":"Theranostics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2967\/jnumed.125.269818","article-title":"Efficacy of [18F]PSMA-1007 PET\/CT in Primary Staging of Prostate Carcinoma: A Systematic Review and Metaanalysis","volume":"67","author":"Rahbar","year":"2026","journal-title":"J. Nucl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.21037\/tau-20-1047","article-title":"Prostate-specific membrane antigen (PSMA)-based imaging in localized and advanced prostate cancer: A narrative review","volume":"10","author":"Aggarwal","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1007\/s00259-021-05210-9","article-title":"Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: A systematic review and network meta-analysis","volume":"48","author":"Alberts","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.19.02757","article-title":"Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline","volume":"38","author":"Trabulsi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41391-023-00755-2","article-title":"Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET\/CT imaging of prostate cancer-a systematic review and meta-analysis","volume":"27","author":"Huang","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.juro.2018.05.164","article-title":"A Clinician\u2019s Guide to Next Generation Imaging in Patients with Advanced Prostate Cancer (RADAR III)","volume":"201","author":"Crawford","year":"2019","journal-title":"J. Urol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1148\/radiol.2018172232","article-title":"Gallium 68 PSMA-11 PET\/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer","volume":"288","author":"Park","year":"2018","journal-title":"Radiology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.7150\/thno.31970","article-title":"Regularized reconstruction of digital time-of-flight 68Ga-PSMA-11 PET\/CT for the detection of recurrent disease in prostate cancer patients","volume":"9","author":"Velikyan","year":"2019","journal-title":"Theranostics"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.eururo.2022.05.010","article-title":"18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography\/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial","volume":"82","author":"Schelfhout","year":"2022","journal-title":"Eur. Urol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1158\/1078-0432.CCR-20-4573","article-title":"Diagnostic Performance of 18F-DCFPyL-PET\/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study","volume":"27","author":"Morris","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.2021202771","article-title":"Prostate-specific Membrane Antigen PET in Prostate Cancer","volume":"299","author":"Salavati","year":"2021","journal-title":"Radiology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1158\/1078-0432.CCR-18-0768","article-title":"PSMA Ligand PET\/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact","volume":"24","author":"Baltzer","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1148\/radiol.2019190687","article-title":"Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET\/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer","volume":"293","author":"Muehlematter","year":"2019","journal-title":"Radiology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1148\/radiol.2018180788","article-title":"Diagnostic Accuracy of 68Ga-PSMA-11 PET\/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer","volume":"289","author":"Hicks","year":"2018","journal-title":"Radiology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00259-024-06847-y","article-title":"The association of quantitative PSMA PET parameters with pathologic ISUP grade: An international multicenter analysis","volume":"52","author":"Soeterik","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hirata, K., and Tamaki, N. (2021). Quantitative FDG PET Assessment for Oncology Therapy. Cancers, 13.","DOI":"10.3390\/cancers13040869"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.eururo.2025.03.003","article-title":"A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment","volume":"87","author":"Mazzone","year":"2025","journal-title":"Eur. Urol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41391-024-00850-y","article-title":"A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET\/CT in the initial staging of prostate cancer","volume":"28","author":"Mari","year":"2025","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Rovera, G., Grimaldi, S., Oderda, M., Marra, G., Calleris, G., Iorio, G.C., Falco, M., Grossi, C., Passera, R., and Campidonico, G. (2024). Comparative Performance of 68Ga-PSMA-11 PET\/CT and Conventional Imaging in the Primary Staging of High-Risk Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy. Diagnostics, 14.","DOI":"10.3390\/diagnostics14171964"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s11912-025-01682-2","article-title":"The Evolving Role of PSMA-PET\/CT in Prostate Cancer Management: An Umbrella Review of Diagnostic Restaging, Therapeutic Redirection, and Survival Impact","volume":"27","author":"Wang","year":"2025","journal-title":"Curr. Oncol. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage Therapy for Prostate Cancer: AUA\/ASTRO\/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J. Urol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","article-title":"Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis","volume":"84","author":"Chow","year":"2023","journal-title":"Eur. Urol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S1470-2045(19)30415-2","article-title":"18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: A prospective, single-centre, single-arm, comparative imaging trial","volume":"20","author":"Calais","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_49","unstructured":"Edge, R., and Picheca, L. (2026, February 28). PET Diagnostic Imaging with Prostate-Specific Membrane Antigen for Prostate Cancer: A Review of Clinical Utility, Cost-Effectiveness, Diagnostic Accuracy, and Guidelines, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567203\/."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Gomis-Sell\u00e9s, E., Maldonado, A., Gazta\u00f1aga, M., Vera, V., Ajulia, O., Sancho, G., Siva, S., Lopez-Campos, F., and Cou\u00f1ago, F. (2025). Impact of PSMA-PET\/CT on Radiotherapy Decisions: Is There a Clinical Benefit?. Cancers, 17.","DOI":"10.3390\/cancers17081350"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2967\/jnumed.117.196683","article-title":"Treatment Outcomes from 68Ga-PSMA PET\/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET","volume":"58","author":"Emmett","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_52","first-page":"1626","article-title":"E-PSMA: The EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Hoffmann, M.A., von Eyben, F.E., Fischer, N., Rosar, F., M\u00fcller-H\u00fcbenthal, J., Buchholz, H.G., Wieler, H.J., and Schreckenberger, M. (2022). Comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 PET\/CT in Restaging of Prostate Cancer Patients with PSA Relapse. Cancers, 14.","DOI":"10.3390\/cancers14061479"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Dorado, C.Q., Ram\u00edrez, A.S., P\u00e9rez, M.P., Centeno, M.S., Mici, L.P., G\u00fcemez, C.M., Albers Acosta, E., Luis, G.C., Costal, M., and Diez, P.T. (2025). Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI-Driven Biomarkers. Cancers, 17.","DOI":"10.20944\/preprints202511.0248.v1"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1148\/radiol.220218","article-title":"18F-DCFPyL PET\/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation","volume":"305","author":"Ulaner","year":"2022","journal-title":"Radiology"},{"key":"ref_56","first-page":"453","article-title":"Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"27","author":"Walz","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41824-023-00182-5","article-title":"Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: Newer horizons for a biopsy-free pathway","volume":"7","author":"Sharma","year":"2023","journal-title":"Eur. J. Hybrid Imaging"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/j.acra.2024.11.029","article-title":"PSMA PET vs. mpMRI for Lymph Node Metastasis of Prostate Cancer: A Systematic Review and Head-to-Head Comparative Meta-analysis","volume":"32","author":"Yang","year":"2025","journal-title":"Acad. Radiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40336-021-00453-w","article-title":"68Ga-PSMA PET\/CT and mpMRI for primary lymph node staging of intermediate to high-risk prostate cancer: A systematic review and meta-analysis of diagnostic test accuracy","volume":"9","author":"Yip","year":"2021","journal-title":"Clin. Transl. Imaging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MOU.0000000000001321","article-title":"Integration of prostate-specific membrane antigen-PET and multiparametric MRI for gross tumour volume definition in localised and locally advanced prostate cancer treated with image-guided radiotherapy","volume":"35","author":"Braat","year":"2025","journal-title":"Curr. Opin. Urol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Midiri, F., Vernuccio, F., Purpura, P., Alongi, P., and Bartolotta, T.V. (2021). Multiparametric MRI and Radiomics in Prostate Cancer: A Review of the Current Literature. Diagnostics, 11.","DOI":"10.3390\/diagnostics11101829"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/MNM.0000000000001850","article-title":"Prostate-specific membrane antigen-PET\/CT may result in stage migration in prostate cancer: Performances, quantitative analysis, and potential criticism in the clinical practice","volume":"45","author":"Alongi","year":"2024","journal-title":"Nucl. Med. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00432-025-06184-z","article-title":"PSMA PET\/CT for prostate cancer diagnosis: Current applications and future directions","volume":"151","author":"Shen","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13550-025-01334-3","article-title":"Local staging of de novo prostate cancer using mpMRI, PSMA-PET and PSMA-PET\/mpMRI\u2014A comparative study","volume":"15","author":"Grefve","year":"2025","journal-title":"EJNMMI Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1007\/s00330-025-11358-x","article-title":"Discordance between prostate MRI and PSMA-PET\/CT: The next big challenge for primary prostate tumor assessment?","volume":"35","author":"Woo","year":"2025","journal-title":"Eur. Radiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2967\/jnumed.121.263159","article-title":"PSMA Expression Assessed by PET Imaging Is a Required Biomarker for Selecting Patients for Any PSMA-Targeted Therapy","volume":"62","author":"Calais","year":"2021","journal-title":"J. Nucl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2967\/jnumed.120.260091","article-title":"Detection efficacy of 18F-rhPSMA-7.3 PET\/CT and impact on management in patients with biochemical recurrence of prostate cancer after radical prostatectomy and before potential salvage treatment","volume":"62","author":"Rauscher","year":"2021","journal-title":"Nucl. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"102076","DOI":"10.1016\/j.clgc.2024.102076","article-title":"An update on the role of mpMRI and 68Ga-PSMA PET imaging in primary and recurrent prostate cancer","volume":"22","author":"Bagheri","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Liu, J., Dunne, J., Touijer, K.A., Perera, M., and Lawrentschuk, N. (2025). The Performance and Role of PSMA PET Scans in Localised Prostate Cancer. Soc. Int. Urol. J., 6.","DOI":"10.3390\/siuj6010010"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13550-025-01265-z","article-title":"A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer","volume":"15","author":"Roberts","year":"2025","journal-title":"EJNMMI Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.eururo.2020.11.043","article-title":"Is Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial","volume":"79","author":"Hofman","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1007\/s00259-023-06332-y","article-title":"Is PSMA PET\/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial","volume":"50","author":"Holzgreve","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e240140","DOI":"10.1148\/radiol.240140","article-title":"Requirements for AI development and reporting for MRI prostate cancer detection in biopsy-naive men: PI-RADS Steering Committee, version 1.0","volume":"315","author":"Turkbey","year":"2025","journal-title":"Radiology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: Screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur. Urol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.semnuclmed.2023.10.002","article-title":"PSMA PET\/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview","volume":"54","author":"Caracciolo","year":"2024","journal-title":"Semin. Nucl. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1007\/s00259-025-07190-6","article-title":"A cost-effectiveness study of PSMA-PET\/CT for the detection of clinically significant prostate cancer","volume":"52","author":"Govers","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Phillipi, M., Choung, D., Ho, E., Anavim, S., Saeed, S., Shu, C., Shi, J., Glavis-Bloom, J., Gupta, A., and Joshi, A. (2025). Diagnostic performance of PSMA PET\/CT, multiparametric MRI, and combined imaging for local prostate cancer recurrence after radical prostatectomy. Abdom. Imaging.","DOI":"10.1007\/s00261-025-05256-5"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"20210683","DOI":"10.1259\/bjr.20210683","article-title":"MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. Results of a phase II trial","volume":"95","author":"Zapatero","year":"2022","journal-title":"Br. J. Radiol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Webster, M., Podgorsak, A., Li, F., Zhou, Y., Jung, H., Yoon, J., Dona Lemus, O., and Zheng, D. (2025). New Approaches in Radiotherapy. Cancers, 17.","DOI":"10.3390\/cancers17121980"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00259-025-07507-5","article-title":"PSMA-Targeted radiopharmaceuticals: From diagnosis to risk & quality of life","volume":"53","author":"Evangelista","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Kunte, S.C., Holzgreve, A., Unterrainer, M., Zahner, J., Schmid, H.P., Sch\u00f6ll, M., Blajan, I., Sheikh, G.T., Mehrens, D., and Casuscelli, J. (2025). Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma. Cancers, 17.","DOI":"10.3390\/cancers17111736"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Argow, M.J., Hupfeld, S., Schenke, S.A., Neumann, S., Damm, R., Vogt, J., Guer, M., Wuestemann, J., Schostak, M., and Fischbach, F. (2025). Comparison of mpMRI and 68Ga-PSMA-PET\/CT in the Assessment of the Primary Tumors in Predominant Low-\/Intermediate-Risk Prostate Cancer. Diagnostics, 15.","DOI":"10.3390\/diagnostics15111358"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Lopez-Valcarcel, M., Lopez-Campos, F., Zafra-Mart\u00edn, J., Cienfuegos Belmonte, I., Subiela, J.D., Ruiz-Vico, M., Fernandez Alonso, S., Garcia Cuesta, J.A., and Cou\u00f1ago, F. (2025). Biomarkers in Localized Prostate Cancer: From Diagnosis to Treatment. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202506.1608.v1"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Urso, L., Badrane, I., Manco, L., Castello, A., Lancia, F., Collavino, J., Crestani, A., Castellani, M., Cittanti, C., and Bartolomei, M. (2025). The Role of Radiomics and Artificial Intelligence Applied to Staging PSMA PET in Assessing Prostate Cancer Aggressiveness. J. Clin. Med., 14.","DOI":"10.3390\/jcm14103318"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00345-025-06163-6","article-title":"Post-HIFU surveillance of localized prostate cancer: Role of PSMA-PET imaging versus the standard PSA\u2013mpMRI protocol","volume":"44","author":"Mercier","year":"2026","journal-title":"World J. Urol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.4102\/sajr.v25i1.2062","article-title":"PI-RADS v2.1: What has changed and how to report","volume":"25","author":"Scott","year":"2021","journal-title":"S. Afr. J. Radiol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Ma, L., Hao, Y., Zhai, L., Zhang, W., Cao, X., and Jia, K. (2025). Which PSMA PET\/CT interpretation criteria most effectively diagnose prostate cancer? a retrospective cohort study. BMC Med. Imaging, 25.","DOI":"10.1186\/s12880-025-01557-9"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eururo.2025.10.013","article-title":"Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE Registry","volume":"89","author":"Karpinski","year":"2025","journal-title":"Eur. Urol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.eururo.2023.06.008","article-title":"Prostate-specific Membrane Antigen Reporting and Data System Version 2.0","volume":"84","author":"Werner","year":"2023","journal-title":"Eur. Urol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13244-024-01699-4","article-title":"Diagnostic performance of MRI in detecting prostate cancer in patients with prostate-specific antigen levels of 4-10\u2009ng\/mL: A systematic review and meta-analysis","volume":"15","author":"Guo","year":"2024","journal-title":"Insights Imaging"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1067\/j.cpradiol.2019.10.009","article-title":"PI-RADS 3 Lesions: Role of Prostate MRI Texture Analysis in the Identification of Prostate Cancer","volume":"50","author":"Giambelluca","year":"2021","journal-title":"Curr. Probl. Diagn. Radiol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Chaddad, A., Tan, G., Liang, X., Hassan, L., Rathore, S., Desrosiers, C., Katib, Y., and Niazi, T. (2023). Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects. Cancers, 15.","DOI":"10.3390\/cancers15153839"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00330-024-11299-x","article-title":"Prostate cancer MRI methodological radiomics score: A EuSoMII radiomics auditing group initiative","volume":"35","author":"Cavallo","year":"2025","journal-title":"Eur. Radiol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Ma, J., Wang, C., Wang, M., Ren, C., Huang, Z., Chen, Y., Xiong, S., Yang, J., Liu, M., and Huo, L. (Eur. J. Nucl. Med. Mol. Imaging, 2026). The integrated diagnostic strategy of performing PSMA PET\/CT followed by MRI improves the diagnostic accuracy of prostate cancer, Eur. J. Nucl. Med. Mol. Imaging, ahead of print.","DOI":"10.1007\/s00259-025-07731-z"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40644-024-00693-9","article-title":"Optimizing PSMA scintigraphy for resource limited settings\u2014A retrospective comparative study","volume":"24","author":"Kolade","year":"2024","journal-title":"Cancer Imaging"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer\u20142024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Saxena, S., Jena, B., Gupta, N., Das, S., Sarmah, D., Bhattacharya, P., Nath, T., Paul, S., Fouda, M.M., and Kalra, M. (2022). Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine. Cancers, 14.","DOI":"10.3390\/cancers14122860"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s41824-025-00280-6","article-title":"Radiomics-based machine learning models for predicting genomic alterations in metastatic prostate cancer using PSMA PET imaging: A pilot study","volume":"9","author":"Scavuzzo","year":"2025","journal-title":"EJNMMI Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1007\/s00259-025-07262-7","article-title":"Insights into pet-based radiogenomics in oncology: An updated systematic review","volume":"52","author":"Filippi","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13550-022-00948-1","article-title":"Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET","volume":"12","author":"Leung","year":"2022","journal-title":"EJNMMI Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"157","DOI":"10.23736\/S1824-4785.25.03640-4","article-title":"The value of artificial intelligence in PSMA PET: A pathway to improved efficiency and results","volume":"69","author":"Dadgar","year":"2025","journal-title":"Q. J. Nucl. Med. Mol. Imaging"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/3\/610\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:42:55Z","timestamp":1774273375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/3\/610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":103,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["medicina62030610"],"URL":"https:\/\/doi.org\/10.3390\/medicina62030610","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}